EMA — authorised 9 December 2020
- Marketing authorisation holder: Novartis Europharm Limited
- Status: approved
🇪🇺 Leqvio in European Union
EMA authorised Leqvio on 9 December 2020
Marketing authorisation
Leqvio in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in European Union
Frequently asked questions
Is Leqvio approved in European Union?
Yes. EMA authorised it on 9 December 2020.
Who is the marketing authorisation holder for Leqvio in European Union?
Novartis Europharm Limited holds the EU marketing authorisation.